CD4 and malaria: Such studies will need to overcome the present lack of reagents to track Ag-specific CD4+ T cells in malaria, due to the tremendous HLA class II diversity, parasite Ag variability and difficulty in characterizing strong P. falciparum-reactive epitopes across human populations.